Balaxi Pharmaceuticals - News
NSE: BALAXI
₹25.90
As on 04-Sep-2026 10:19IST
Market cap
₹147 Cr
Revenue (TTM)
₹280 Cr
P/E Ratio
60.6
P/B Ratio
0.6
Div. Yield
0 %
Announcements
View AnnouncementsAlteration Of Capital and Fund Raising-XBRL
25-Jan-2024No News & Announcements are available.